
Bioretec Q1'26: The beginning of the year offered positive signs
Bioretec's Q1 earnings positively surprised in terms of revenue and profit, particularly due to growth in the US and European markets. Bioretec's CEO, Sarah Hubar-Fisher, tells more about the first quarter in an interview with analyst Antti Siltanen.
Topics:
00:00 Introduction
00:15 Positive signs from the beginning of the year
01:41 Drivers behind the numbers
02:39 RemeOs sales
03:08 Orders affecting the comparison period
04:00 Taking RemeOs to China
04:37 Expanding the distributor network
05:35 Recruitment situation
06:30 Operational priorities for the rest of the year
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.